Join
Live feed
·
INSIDERFilingvia Quantisnow
Tenax Therapeutics Inc. logo

Chief Financial Officer Staab Thomas R Ii bought $10,981 worth of shares (5,675 units at $1.94), increasing direct ownership by 57% to 15,675 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TENX· Tenax Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TENX (Tenax Therapeutics Inc.) and more on Quantisnow.